Hanssens 2007.

Trial name or title	NCT 00508157 CN 138‐489
Methods	Allocation: random, no further details Blindness: open label. Duration: 16 weeks. Design: parallel. Location: multicentre.
Participants	Diagnosis: schizophrenia. Age 18‐65 years. Gender: male/female participants. History: duration of illness not reported. Setting: not reported.
Interventions	1. Aripiprazole. 2. Olanzapine. 3. Risperidone. 4. Quetiapine.
Outcomes	Change from baseline in fasting non‐ HDL cholesterol.
Starting date	July 2007.
Contact information	Bristol ‐Myers Squibb.
Notes